Mosaic embryos after PGT-A: what the result means, what it does not, and why lab policy matters

“Mosaic” sounds like a known percentage of normal and abnormal cells. ASRM is more cautious: modern PGT-A usually infers mosaicism from an intermediate copy-number signal in DNA from a small trophectoderm biopsy.

Why the word is complicated

ASRM notes possible contributions from true mosaicism, amplification bias, contamination, noise, biopsy technique, mitotic state, and lab methodology.

Different labs can classify differently

Platforms, cutoffs, software, and reporting policies vary enough that classification can differ across laboratories.

Can mosaic embryos implant?

Yes. Thousands have been transferred and healthy births reported. Some studies show lower implantation and higher miscarriage than euploid transfer.

Fetal risk

ASRM describes fetal/neonatal confirmation related to the original mosaic result as uncommon in available data, while emphasizing uncertainty and recommending prenatal counseling/testing discussion.

Can mosaics be ranked?

Clinics consider level, segmental vs whole-chromosome findings, and chromosome involved, but no fully evidence-based ranking method predicts outcome across all labs.

Genetic counseling

ASRM recommends genetic counseling for patients considering mosaic transfer.

Clinic policy matters

Some programs transfer selected mosaics; some restrict categories; some do not. Ask before testing, especially if you may have no euploid embryos.

Questions

• Which lab?
• What threshold defines mosaic?
• Segmental or whole chromosome?
• Will your clinic transfer it?
• What prenatal testing would be discussed?

FAQ

A mosaic PGT-A result is probabilistic biopsy information, not a complete genetic map of the embryo.

Low-level versus high-level mosaic labels

Patients often receive percentages or categories such as low-level and high-level mosaic. Those labels depend on the genetics lab's assay and reporting thresholds, which is exactly why ASRM cautions against assuming one laboratory's categories transfer cleanly to another.

Segmental versus whole-chromosome findings

Segmental mosaic findings involve part of a chromosome rather than the whole chromosome. ASRM notes that some segmental findings may be more vulnerable to technical artifact and may show different reproductive patterns, but prenatal risk prediction remains uncertain.

Prenatal testing after mosaic transfer

Screening and diagnostic options should be discussed with a genetics professional. A pregnancy after mosaic transfer deserves individualized prenatal counseling rather than assuming the PGT-A result is either meaningless or definitive.

Why “discard” is a consequential word

Because healthy births have occurred after mosaic-result transfers and because test interpretation carries uncertainty, embryo-disposition decisions deserve informed consent, genetics counseling, and awareness of transport/storage options.

How to use this information in a real IVF consultation

Bring the numbers from your own cycle and ask the clinician to interpret the pattern rather than discussing the topic abstractly. IVF decisions become much clearer when the conversation moves from “What does this test mean?” to “What did this test and my last cycle together teach us about the next cycle?”

Ask what would actually change because of the finding: protocol, dose, trigger, fertilization method, culture strategy, transfer timing, genetic counseling, or nothing. If a test or label does not change management, understand why it is being ordered.

Keep the treatment funnel visible

Egg count, maturity, fertilization, blastocyst formation, genetic status, transfer, implantation, and live birth are different checkpoints. A strong result at one checkpoint improves opportunity but never guarantees success at the next. Good counseling keeps those denominators separate.

What this result should not be allowed to do

One laboratory value, one embryo label, or one disappointing cycle should not collapse the entire treatment conversation into a single verdict. Fertility treatment is probabilistic. The value of a result is in how it changes the next decision, not in how dramatic the number sounds on a portal screen.

Ask the clinic to separate three things explicitly: what is known from your data, what is inferred from population averages, and what remains uncertain. That distinction is especially important when a recommendation carries additional cost, another invasive procedure, embryo-disposition consequences, or an unproven add-on.

What a good second opinion should review

• The raw cycle numbers rather than only the final outcome
• Medication doses and stimulation timeline
• Trigger type and timing where relevant
• Egg maturity and fertilization counts
• Day-by-day embryo development
• Genetic-testing reports where applicable
• Transfer preparation and procedure notes
• Prior uterine/sperm evaluation that could change management

A second opinion is most useful when the new clinician can see the same underlying data as the first clinic. Otherwise you are comparing interpretations built from different information.

How to compare clinics on this topic

Ask how the program tracks its own outcomes for patients with a similar age, diagnosis, and cycle pattern. A good laboratory or fertility program should be able to explain its process without pretending that one protocol, grading system, or add-on works for everyone. Specificity is more useful than superlatives.

Decision checkpoint before the next cycle

Before another stimulation, retrieval, biopsy, or transfer begins, write down the one or two decisions this information is supposed to change. Examples include changing starting dose, changing trigger strategy, choosing conventional insemination versus ICSI, altering culture strategy, choosing a different FET preparation, seeking genetics counseling, or deciding that no change is justified. This prevents retrospective data from becoming expensive trivia.

Then ask what result would make the clinic reverse course. A treatment plan is more credible when the clinician can describe both the reason to use it and the finding that would make them stop using it.

Keep cumulative outcomes separate from per-step percentages

Fertility statistics are easy to make sound better by changing denominators. Fertilization rate is per mature oocyte, blastocyst rate can be reported per fertilized egg or per embryo still in culture, implantation is per transfer, and live birth can be per transfer, per retrieval, or cumulative across a complete egg cohort. When a clinic gives you a percentage, ask for the denominator.

For patients planning more than one retrieval or more than one frozen transfer, cumulative chance across the entire cohort can be more meaningful than the best-looking single-transfer statistic. That is also why avoiding unnecessary embryo discard, unnecessary cycle cancellation, and unsupported add-ons can matter to the overall strategy.